Vault-13

Healthcare Value Capital, LLC

Woodcliff Lake, NJ · CIK 1458461 · 13F filing filed 2021-08-16

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$46.2m reported value +18.0% vs Q1 2021
18positions
73.7%in top 10
1 new 9 added 0 reduced 1 sold out vs Q1 2021

Options: 5 call positions ($3.9m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 GILEAD SCIENCES INC COM GILD GILD 75,000 $5.2m11.17% 11.17% UnchangedShares held: Q3 2020 50.0k, Q4 2020 50.0k, Q1 2021 75.0k, Q2 2021 75.0k
2 GLAXOSMITHKLINE PLC SPONSORED ADR SPONSORED ADR 100,000 $4.0m8.61% 8.61% UnchangedShares held: Q3 2020 100.0k, Q4 2020 100.0k, Q1 2021 100.0k, Q2 2021 100.0k
3 PFIZER INC COM PFE PFE 100,000 $3.9m8.47% 8.47% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 100.0k, Q2 2021 100.0k
4 ALKERMES PLC SHS ALKS ALKS 150,000 $3.7m7.95% 7.95% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 100.0k, Q2 2021 150.0k +50.0k +50,000 50.0%
5 BRISTOL-MYERS SQUIBB CO COM BMY BMY 50,000 $3.3m7.23% 7.23% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 25.0k, Q2 2021 50.0k +25.0k +25,000 100.0%
6 MERCK & CO INC COM MRK MRK 40,000 $3.1m6.73% 6.73% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 20.0k, Q2 2021 40.0k +20.0k +20,000 100.0%
7 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 50,000 $3.0m6.48% 6.48% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 25.0k, Q2 2021 50.0k +25.0k +25,000 100.0%
8 CLOVIS ONCOLOGY INC COM CLVS CLVS 500,000 $2.9m6.27% 6.27% AddedShares held: Q3 2020 250.0k, Q4 2020 250.0k, Q1 2021 450.0k, Q2 2021 500.0k +50.0k +50,000 11.1%
9 IRONWOOD PHARMACEUTICALS INC COM CL A IRWD IRWD 200,000 $2.6m5.57% 5.57% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 200.0k, Q2 2021 200.0k
10 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 200,000 $2.4m5.25% 5.25% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 155.6k, Q2 2021 200.0k +44.4k +44,445 28.6%
11 COLLEGIUM PHARMACEUTICAL INC COM COLL COLL 100,000 $2.4m5.11% 5.11% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 100.0k, Q2 2021 100.0k
12 ANTARES PHARMA INC COM ATRS ATRS 500,000 $2.2m4.71% 4.71% UnchangedShares held: Q3 2020 500.0k, Q4 2020 500.0k, Q1 2021 500.0k, Q2 2021 500.0k
13 TYME TECHNOLOGIES INC COM TYME TYME 1,500,000 $1.9m4.09% 4.09% UnchangedShares held: Q3 2020 2.2m, Q4 2020 2.2m, Q1 2021 1.5m, Q2 2021 1.5m
14 VYNE THERAPEUTICS INC COM COM 450,000 $1.6m3.42% 3.42% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 400.0k, Q2 2021 450.0k +50.0k +50,000 12.5%
15 GREENLANE HLDGS INC CL A CL A 350,000 $1.6m3.38% 3.38% AddedShares held: Q3 2020 250.0k, Q4 2020 250.0k, Q1 2021 250.0k, Q2 2021 350.0k +100.0k +100,000 40.0%
16 MIMEDX GROUP INC COM MDXG MDXG 125,000 $1.6m3.38% 3.38% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 125.0k
17 ADAMAS PHARMACEUTICALS INC COM ADMS ADMS 100,000 $528.0k1.14% 1.14% UnchangedShares held: Q3 2020 100.0k, Q4 2020 100.0k, Q1 2021 100.0k, Q2 2021 100.0k
18 GAMIDA CELL LTD SHS SHS 75,000 $481.0k1.04% 1.04% AddedShares held: Q3 2020 0, Q4 2020 50.0k, Q1 2021 50.0k, Q2 2021 75.0k +25.0k +25,000 50.0%

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
AURINIA PHARMACEUTICALS INC AUPH AUPH 100,000 $1.3m100.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
PROSHARES TR Call Call 100,000 $914.0k100.0k shares New
PROSHARES TR Call Call 50,000 $911.0k50.0k shares Reduced
AMARIN CORP PLC Call Call 200,000 $876.0k200.0k shares Reduced
IRONWOOD PHARMACEUTICALS INC IRWD · Call IRWDCall 50,000 $644.0k50.0k shares Unchanged
PROSHARES TR II Call Call 25,000 $602.0k25.0k shares New